Skip to content
94 result(s)

Home Medical Affairs

Get access to the latest news and research in medical affairs with this comprehensive portal. Stay up-to-date with the latest clinical trials, studies, and developments in the medical field. Explore a variety of resources to enhance your knowledge and stay informed.

Contact Us Confirmation

Solicite la visita de uno de nuestros delegados de GSK- Confirmación

GSK Medical Affairs - Contact

Contacte con el centro de información, solicite la visita de un delegado o el contacto por el departamento médico, Notifique de una sospecha de reacción adversa

Characteristics of severe eosinophilic asthma

Severe asthma with eosinophilic phenotype is a distinct phenotype of severe asthma. This phenotype is characterized by airway inflammation, increased blood/sputum eosinophil (EOS) concentrations, poor asthma control, and increased rate of exacerbations.

Impact of varying health status thresholds on disease stability in COPD with FF/UMEC/VI: IMPACT post hoc analysis.​

Halpin MGD, et al. ​By demonstrating the effect of inhaled therapies on measures of health status (SGRQ and CAT) according to different thresholds, it may be possible to better assess disease stability in clinical practice. Disease stability should be considered an ambitious, practical and realisable treatment goal for patients with COPD, with the potential to guide patient management. Poster PA1173

Impact of varying lung function thresholds on disease stability in COPD with FF/UMEC/VI: IMPACT post hoc analysis.​

Halpin MGD, et al. ​By demonstrating the effect of inhaled therapies on different lung function thresholds, it may be possible to better assess disease stability in clinical practice. Disease stability should be considered an ambitious, practical and realisable treatment goal for patients with COPD, with the potential to guide patient management. Presentation OA4653

Towards disease stability in COPD management: patient perspectives​

Brooke M, et al​. Patient advocacy advisors highlight disease stability as a desirable treatment goal for COPD, driven by patient aspirations and clinical characteristics. Personalisation of treatment strategies and patient care underpins the achievement and maintenance of disease stability resulting in improvements to the quality of life for patients living with COPD. Poster PA1171

ERS 2024 SOOTHE Study Poster

Smith JA, et al. Prior and concomitant medication use in patients with refractory chronic cough: post-hoc analysis of SOOTHE. ERS 2024. Poster No. PA319

Expert video describing disease stability

Video by Prof Dave Singh and Prof MeiLan Han describing disease stability and what it might mean for patients.

Refractory Chronic Cough Patient Story video

Short Video of RCC patient sharing the burden of this disease

RCC Mechanism of Disease Loop Video

Short video looking at the pathophysiology of refractory chronic cough

ERS 2024 Asthma Symposium - Summary

Can we break through the therapeutic ceiling in severe asthma? Prof. Celeste Porsbjerg - Professor of Severe Asthma - Bispebjerg Hospital, Denmark

ERS 2024 Asthma Symposium

Full symposium recording of Can we break through the therapeutic ceiling in severe asthma? Prof. Celeste Porsbjerg - Professor of Severe Asthma - Bispebjerg Hospital, Denmark

Impact of varying lung function threshold on clinical remission in asthma with FF/UMEC/VI: CAPTAIN post hoc analysis.​

Poster PA1199 from ERS 2024 presenting post hoc analysis of clinical remission from the CAPTAIN study. 

Assessment of the components of clinical remission with moderate–severe asthma after 24–52 weeks of treatment: CAPTAIN post hoc analysis​

Poster PA1198 from ERS 2024 presenting post hoc analysis of clinical remission from the CAPTAIN study.

Characteristics of patients meeting the components of clinical remission: CAPTAIN post hoc analysis.​

Poster PA1197 from ERS 2024 presenting post hoc analysis of clinical remission from the CAPTAIN study. 

ERS 2024 - COPD Portfolio Symposium

Full recording of Striving for Disease Stability in COPD. Giving patients more if their best days. Co-Chairs by Meilan K. Han and Dave Singh Prof. MeiLan Han: Prof of Medicine, Divison of Pulmonary and Critical Care - University of Michigan, USA. Prof. Dave Singh: Prof of Respiratory Pharmacology, University of Manchester, UK. Dr. Lowie Vanfleteren: Head of the COPD Center - Sahgrenska University Hospital, Goffenburg, Sweden.

CAPTAIN Clinical Remission ERS Poster Mod-Sev Audio for poster PA 1197

Audio to support poster PA1197 from ERS 2024 presenting the post hoc analysis of clinical remission from the CAPTAIN study.

CAPTAIN Clinical Remission ERS lung function; audio for poster PA1199

Audio to support poster PA1197 from ERS 2024 presenting the post hoc analysis of clinical remission from the CAPTAIN study.

CAPTAIN Clinical Remission ERS baseline; audio for poster PA1198

Audio to support poster PA1197 from ERS 2024 presenting the post hoc analysis of clinical remission from the CAPTAIN study.

Clinical Remission in Asthma

A collection of materials addressing Clinical Remission in asthma which is an ambitious but attainable treatment goal for patients with asthma irrespective of disease severity and treatment history

CAPTAIN Study main results video

The CAPTAIN study provides robust evidence to support, and better tailor, the use of triple therapy in asthma using a precision medicine approach. In this video, Professor Ian Pavord presents the main results from the CAPTAIN study

AAAAI 2024 CAPTAIN study post-hoc Clinical Remission oral presentation (key take aways video)

Video recording of Prof. Oppenheimer presenting key takeaways from the CAPTAIN clinical remission post hoc analysis results from AAAAI 2024

Audio for the FULFIL Study Post Hoc Analysis Poster P630 at ATS 2024

Audio of Prof. David Singh presenting the FULFIL Study Post Hoc Analysis at ATS 2024

CAPTAIN Study sub-group analysis video

The CAPTAIN study provides robust evidence to support, and better tailor, the use of triple therapy in asthma using a precision medicine approach. In this video, Professor Ian Pavord presents a sub-group analysis from the CAPTAIN study exploring the impact of type 2 biomarker status on outcomes.

What is Clinical Remission concept video

Video recording of Prof. Oppenheimer providing an overview of clinical remission in asthma

Audio for the FULFIL Study Post Hoc Analysis Poster P630 at ATS 2024

Audio of Prof. David Singh presenting the FULFIL Study Post Hoc Analysis at ATS 2024

GAA May Webinar_ Lavoie Pre-recorded video

GSK-GAA Webinar 2024: Optimising evidence through a patient-centred approach

GAA May Webinar_ Panel Pre-recorded video

GSK-GAA Webinar 2024: Panel Discussion

MoD video (localisable version)

Short video summarising the IL-5 biology and recent evidence surrounding this science, as well as the cells impacted directly and indirectly by the IL-5 pathway.

uUTI Mechanism of Disease Video

The CAPTAIN study provides robust evidence to support, and better tailor, the use of triple therapy in asthma using a precision medicine approach. In this video, Professor Ian Pavord presents the main results from the CAPTAIN study

GAA May Webinar_ Yorgancıoğlu Pre-recorded video

GSK-GAA Webinar 2024: Personalized Asthma Care in the Clinic - Applying the latest evidence

NMA in Triple Therapy summary

For FF/UMEC/VI, the NMA suggest favourable efficacy compared with other single-inhaler triple therapies.

CAPTAIN Study Clinical Remission Poster: ATS 2024

Poster from ATS 2024 presenting the post hoc analysis of clinical remission from the CAPTAIN study. 

NMA in Triple Therapy: Class comparison data in COPD

FF/UMEC/VI versus triple and dual bronchodilator therapies

The EMAX trial

Asthma is a heterogeneous disease and its management is multifactorial; many patients often remained uncontrolled despite treatment. HCPs have a critial role in identifying and managing patients who are not adequately controlled, which involves: -Regular discussions with patients -Recognition of symptoms and exacerbation risks -Continuous assessment of treatment -Reassessment of treatment and follow-up

Inhaled molecules for COPD treatment

How does molecule pharmacology correlate with clinical efficacy and safety? Pharmacological properties of inhaled respiratory molecules are critical to ensure the best possible clinical outcomes.

Network Meta-analysis (NMA) introduction for Triple Therapy

Comparing efficacy of triple therapies among patients with COPD. Multiple RCTs have demonstrated the benefit of triple over dual inhaled therapy in improving lung function and reducing the risk of exacerbation for patients with COPD

Inhalers in Respiratory Medicine > Unmet Need

In this section the symptom burden and unmet needs of patients with COPD are discussed, as well as the importance of correct inhaler technique and the impact of multiple inhaler therapy.

Inhalers in Respiratory Medicine >Patient Benefits

What are the key considerations affecting inhaler choice, from a patient and physician perspective?

Inhalers in Respiratory Medicine >Clinical Efficacy

Clinical efficacy of inhaled therapy delivered via the Ellipta inhaler. As well as ease of use, and fewer patients making an error with their inhaler, treatments are needed that show clinical efficacy.

RWE interactive map 2024

An interactive map displaying RWE studies in asthma, CRSwNP, EGPA, COPD and HES

EAACI 2024: Medical booth IL-5 digital infographic

Interactive pdf explaining the impact of IL-5 beyond eosinophils on cells. including its role in a variety of pathophysiological processes

AAAAI 2024 CAPTAIN study post-hoc Clinical Remission oral presentation (full video)

Video recording of Prof. Oppenheimer presenting key takeaways from the CAPTAIN clinical remission post hoc analysis results from AAAAI 2024

CAPTAIN Study Clinical Remission Poster: ATS 2024

Poster from ATS 2024 presenting the post hoc analysis of clinical remission from the CAPTAIN study. 

Medical COPD portfolio symposium summary video_ERS 2024

Short video with the faculty, summarising the key takeaways of the symposium.

Talking Head Video

Short Talking Head Videos outlining the unmet need in Refractory Chronic Cough and the importance of early recognition

Load more

Thank you for your query. We're sorry, but we don't find information about this topic:
Here are some steps that you can take to improve the accuracy of your search:

  • Check the spelling of your search.
  • Try a different wording.
  • Reset or review the filters applied (if filters were used to perform this search).
  • Check the accuracy of your search terms.
  • Try using multiple keywords to narrow down your search.
  • Try using synonyms or related words to broaden your search.